Transcriptome profiling of Korean colon cancer by cDNA PCR Nanopore sequencing
)
- We have sequenced 20 pairs of Korean colon cancer patients using cDNA PCR Nanopore technology to identify colon cancer specific novel biomarkers that can be used for clinical usage.
- We attempted to identify novel isoform, non-coding RNAs and fusion genes. Some candidates that were found were shown to have potential to be new colon cancer diagnostic biomarkers.
- By using more precise and accurate data to detect such biomarkers, we want not only to be able to use them for clinical usage, but also to further propose a new molecular mechanism to better understand colon cancer tumorigenesis using Nanopore data.